Abstract:In the last years, the extracellular matrix (ECM) has been reported as playing a relevant role in esophageal cancer (EC) development, with this compartment being related to several aspects of EC genesis and progression. This sounds very interesting due to the complexity of this highly incident and lethal tumor, which takes the sixth position in mortality among all tumor types worldwide. The well-established increase in ECM stiffness, which is able to trigger mechanotransduction signaling, is capable of regulating several malignant behaviors by converting alteration in ECM mechanics into cytoplasmatic biochemical signals. In this sense, it has been shown that some molecules play a key role in these events, particularly the different collagen isoforms, as well as enzymes related to its turnover, such as lysyl oxidase (LOX) and matrix metalloproteinases (MMPs). In fact, MMPs are not only involved in ECM stiffness, but also in other events related to ECM homeostasis, which includes ECM remodeling. Therefore, the crucial role of distinct MMPs isoform has already been reported, especially MMP-2, -3, -7, and -9, along EC development, thus strongly associating these proteins with the control of important cellular events during tumor progression, particularly in the process of invasion during metastasis establishment. In addition, by distinct mechanisms, a vast diversity of glycoproteins and proteoglycans, such as laminin, fibronectin, tenascin C, galectin, dermatan sulfate, and hyaluronic acid exert remarkable effects in esophageal malignant cells due to the activation of oncogenic signaling pathways mainly involved in cytoskeleton alterations during adhesion and migration processes. Finally, the wide spectrum of interactions potentially mediated by ECM may represent a singular intervention scenario in esophageal carcinogenesis natural history and, due to the scarce knowledge on the cellular and molecular mechanisms involved in EC development, the growing body of evidence on ECM’s role along esophageal carcinogenesis might provide a solid base to improve its management in the future.

The Importance of the Extracellular Matrix in HPV-Associated Diseases

Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Extracellular matrix and its therapeutic potential for cancer treatment

The Role of Extracellular Matrix Proteins in Breast Cancer

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

Extracellular matrix remodeling in the tumor immunity

Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix

The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets

The Functional Role of Extracellular Matrix Proteins in Cancer

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

The Role of Extracellular Matrix Proteins in Pathogenesis

Biological implications of decoding the extracellular matrix of vulva cancer

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Extracellular matrix endocytosis in controlling matrix turnover and beyond: emerging roles in cancer.

The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer

The extracellular matrix modulates the hallmarks of cancer

Extracellular Matrix in Mammary Gland Development and Breast Cancer Progression